BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19689407)

  • 21. A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women.
    Carmina E; Lobo RA
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):231-4. PubMed ID: 12153602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of oral contraceptives in the treatment of hyperandrogenic disorders.
    Burkman RT
    Am J Med; 1995 Jan; 98(1A):130S-136S. PubMed ID: 7825633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action.
    Furr BJ; Tucker H
    Urology; 1996 Jan; 47(1A Suppl):13-25; discussion 29-32. PubMed ID: 8560673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical relevance of testosterone and dihydrotestosterone metabolism in women.
    Rittmaster RS
    Am J Med; 1995 Jan; 98(1A):17S-21S. PubMed ID: 7825635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of hyperandrogenic manifestations in polycystic ovary syndrome].
    Bednarek-Tupikowska G; Milewicz A; Bohdanowicz-Pawlak A; Bidzińska B; Szymczak J
    Pol Tyg Lek; 1993 Jul 5-12; 48(27-28):620-3. PubMed ID: 8090657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of antiandrogens as therapy for women with polycystic ovary syndrome.
    Moghetti P
    Fertil Steril; 2006 Jul; 86 Suppl 1():S30-1. PubMed ID: 16798285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hair loss in women.
    Camacho-Martínez FM
    Semin Cutan Med Surg; 2009 Mar; 28(1):19-32. PubMed ID: 19341939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developmental Programming: Insulin Sensitizer Prevents the GnRH-Stimulated LH Hypersecretion in a Sheep Model of PCOS.
    Cardoso RC; Burns A; Moeller J; Skinner DC; Padmanabhan V
    Endocrinology; 2016 Dec; 157(12):4641-4653. PubMed ID: 27792406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide antagonist of the androgen receptor.
    Gao W
    Curr Pharm Des; 2010; 16(9):1106-13. PubMed ID: 20030610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hormonal antiandrogens in acne treatment].
    Zouboulis CC; Rabe T
    J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S60-74. PubMed ID: 20482693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and biological evaluation of novel androst-17β-amide structurally related compounds as dual 5α-reductase inhibitors and androgen receptor antagonists.
    Lao K; Xun G; Gou X; Xiang H
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1597-1606. PubMed ID: 31469015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical treatment regimens of hirsutism.
    Sahin Y; Kelestimur F
    Reprod Biomed Online; 2004 May; 8(5):538-46. PubMed ID: 15151716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acne vulgaris: endocrine aspects].
    Dekkers OM; Thio BH; Romijn JA; Smit JW
    Ned Tijdschr Geneeskd; 2006 Jun; 150(23):1281-5. PubMed ID: 16821451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
    Paris F; Rabeolina F; Balaguer P; Bacquet A; Sultan C
    Gynecol Endocrinol; 2007 Apr; 23(4):193-7. PubMed ID: 17505938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgens and therapeutic aspects of antiandrogens in women.
    Diamanti-Kandarakis E; Tolis G; Duleba AJ
    J Soc Gynecol Investig; 1995; 2(4):577-92. PubMed ID: 9420861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of pharmaceutical compounds on male fertility.
    Neumann F; Diallo FA; Hasan SH; Schenck B; Traore I
    Andrologia; 1976; 8(3):203-35. PubMed ID: 793446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sebocytes are the key regulators of androgen homeostasis in human skin.
    Fritsch M; Orfanos CE; Zouboulis CC
    J Invest Dermatol; 2001 May; 116(5):793-800. PubMed ID: 11348472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.
    Clark RV; Hermann DJ; Cunningham GR; Wilson TH; Morrill BB; Hobbs S
    J Clin Endocrinol Metab; 2004 May; 89(5):2179-84. PubMed ID: 15126539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.
    Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.